Senores Pharmaceuticals Statistics

Total Valuation

BOM:544319 has a market cap or net worth of INR 25.67 billion. The enterprise value is 25.22 billion.

Market Cap	25.67B
Enterprise Value	25.22B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.05M
Shares Outstanding	n/a
Shares Change (YoY)	+562.54%
Shares Change (QoQ)	+37.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.36M

Valuation Ratios

The trailing PE ratio is 43.83 and the forward PE ratio is 20.44.

PE Ratio	43.83
Forward PE	20.44
PS Ratio	6.45
PB Ratio	3.16
P/TBV Ratio	4.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.12, with an EV/FCF ratio of -12.40.

EV / Earnings	43.07
EV / Sales	6.33
EV / EBITDA	28.12
EV / EBIT	34.62
EV / FCF	-12.40

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.39.

Current Ratio	3.00
Quick Ratio	2.12
Debt / Equity	0.39
Debt / EBITDA	3.51
Debt / FCF	-1.55
Interest Coverage	3.38

Financial Efficiency

Return on equity (ROE) is 11.18% and return on invested capital (ROIC) is 5.63%.

Return on Equity (ROE)	11.18%
Return on Assets (ROA)	4.93%
Return on Invested Capital (ROIC)	5.63%
Return on Capital Employed (ROCE)	7.39%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	113
Asset Turnover	0.43
Inventory Turnover	3.84

Taxes

In the past 12 months, BOM:544319 has paid 122.30 million in taxes.

Income Tax	122.30M
Effective Tax Rate	17.33%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	524.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	64.73
Average Volume (20 Days)	18,559

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544319 had revenue of INR 3.98 billion and earned 585.60 million in profits. Earnings per share was 16.12.

Revenue	3.98B
Gross Profit	2.18B
Operating Income	728.60M
Pretax Income	705.70M
Net Income	585.60M
EBITDA	897.00M
EBIT	728.60M
Earnings Per Share (EPS)	16.12

Full Income Statement

Balance Sheet

The company has 3.86 billion in cash and 3.15 billion in debt, giving a net cash position of 707.50 million.

Cash & Cash Equivalents	3.86B
Total Debt	3.15B
Net Cash	707.50M
Net Cash Per Share	n/a
Equity (Book Value)	8.12B
Book Value Per Share	168.00
Working Capital	4.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -459.20 million and capital expenditures -1.58 billion, giving a free cash flow of -2.03 billion.

Operating Cash Flow	-459.20M
Capital Expenditures	-1.58B
Free Cash Flow	-2.03B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 54.63%, with operating and profit margins of 18.30% and 14.70%.

Gross Margin	54.63%
Operating Margin	18.30%
Pretax Margin	17.72%
Profit Margin	14.70%
EBITDA Margin	22.52%
EBIT Margin	18.30%
FCF Margin	n/a

Dividends & Yields

BOM:544319 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-562.54%
Shareholder Yield	n/a
Earnings Yield	2.28%
FCF Yield	-7.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4